Wednesday, June 24, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 878 of 1,261

  1. US 8415294

    Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth

    THE ARIZONA BOARD OF REGENTS · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  2. US 8415302

    Surgical applications for BMP binding protein

    The Regents of the University of California · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  3. US 8414909

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  4. US 8415396

    Colchine compositions and methods

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  5. US 8414890

    Human antibodies to human RANKL, encoding nucleic acids and methods of treatment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  6. US 8415387

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  7. US 8415332

    Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

    Teva Womans's Health, Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted

  8. US 8410274

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  9. US 8409616

    Extended release opioid abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  10. US 8410073

    Methods and compositions for prevention or treatment of RSV infection

    Alnylam Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  11. US 8409632

    Product containing extract from Zanthoxylum avicennae (Lam.) DC., and preparation process and use thereof

    China Medical University · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  12. US 8410112

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  13. US 8409566

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Northwest Biotherapeutics, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  14. US 8410272

    Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

    Dermira (Canada), Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  15. US 8410087

    Indole compound

    Takeda Pharmaceutical Company Limited · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  16. US 8410261

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  17. US 8410292

    Epoxy-guaiane derivatives and treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  18. US 8409548

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  19. US 8410267

    Regioselective reduction of fused pyrrolocarbazoles-5,7-diones

    Teva Sante · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  20. US 8410266

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  21. US 8410169

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  22. US 8410140

    Anesthetic methods and compositions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  23. US 8409602

    Sealants for fetal membrane repair

    Northwestern University · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

  24. US 8410288

    Polymorphs of Saxagliptin hydrochloride and processes for preparing them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.